These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 8141448

  • 1. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
    Slaughter TF, LeBleu TH, Douglas JM, Leslie JB, Parker JK, Greenberg CS.
    Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prothrombin fragments F1+2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis.
    Giannitsis E, Siemens HJ, Mitusch R, Tettenborn I, Wiegand U, Schmücker G, Sheikhzadeh A, Stierle U.
    Int J Cardiol; 1999 Mar 15; 68(3):269-74. PubMed ID: 10213277
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction.
    Scharfstein JS, Abendschein DR, Eisenberg PR, George D, Cannon CP, Becker RC, Sobel B, Cupples LA, Braunwald E, Loscalzo J.
    Am J Cardiol; 1996 Sep 01; 78(5):503-10. PubMed ID: 8806332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A, Fischer T, Praus M, Haberzettl H, Kuebler WM, Hetzer R, Kuppe H.
    Anesthesiology; 2002 Oct 01; 97(4):837-41. PubMed ID: 12357148
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of antithrombin III in the perioperative management of the patient with unstable angina.
    Rossi M, Martinelli L, Storti S, Corrado M, Marra R, Varano C, Schiavello R.
    Ann Thorac Surg; 1999 Dec 01; 68(6):2231-6. PubMed ID: 10617008
    [Abstract] [Full Text] [Related]

  • 12. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
    Dietrich W, Mössinger H, Spannagl M, Jochum M, Wendt P, Barankay A, Meisner H, Richter JA.
    J Thorac Cardiovasc Surg; 1993 Apr 01; 105(4):712-20. PubMed ID: 7682267
    [Abstract] [Full Text] [Related]

  • 13. Markers of activated hemostasis and fibrinolysis in patients with pulmonary malignancies: comparison of plasma levels in central venous and pulmonary venous blood.
    Kalweit GA, Feindt P, Micek M, Gams E, Hellstern P.
    Thromb Res; 2000 Feb 01; 97(3):105-11. PubMed ID: 10680641
    [Abstract] [Full Text] [Related]

  • 14. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ, Weerwind PW, Bogdan S, Verbruggen H, Brouwer MH.
    Perfusion; 2001 Jan 01; 16(1):3-12. PubMed ID: 11192305
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of combined anticoagulation using heparin and bivalirudin on the hemostatic and inflammatory responses to cardiopulmonary bypass in the rat.
    Welsby IJ, Jones WL, Arepally G, De Lange F, Yoshitani K, Phillips-Bute B, Grocott HP, Becker R, Mackensen GB.
    Anesthesiology; 2007 Feb 01; 106(2):295-301. PubMed ID: 17264724
    [Abstract] [Full Text] [Related]

  • 17. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
    Cadroy Y, Pierrejean D, Fontan B, Sié P, Boneu B.
    Nouv Rev Fr Hematol (1978); 1992 Feb 01; 34(1):43-6. PubMed ID: 1523099
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
    Dietrich W.
    J Cardiovasc Pharmacol; 1996 Feb 01; 27 Suppl 1():S50-7. PubMed ID: 8938284
    [Abstract] [Full Text] [Related]

  • 20. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C, Gruenwald CE, Holtby HM, Brandão LR, Chan AK, Van Arsdell GS, McCrindle BW.
    J Thorac Cardiovasc Surg; 2016 Feb 01; 151(2):444-50. PubMed ID: 26553458
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.